胰腺对比增强CT影像组学特征的可重复性受扫描参数和手动分割变异的影响
该回顾性研究纳入37对间隔2周内的胰腺对比增强CT扫描,评估266个影像组学特征在胰腺实质和胰腺导管腺癌中的可重复性。结果显示扫描间变异对特征可重复性的影响大于分割者间变异,且胰腺肿瘤来源的可重复特征少于胰腺实质来源的特征。
要点
- 扫描间变异比分割者间变异更影响影像组学特征的可重复性。
- 以CCC>0.90为阈值,胰腺实质特征在分割者间场景下可重复比例最高为21.8%。
- 胰腺肿瘤来源特征的可重复比例低于胰腺实质来源特征。
核心结论
- 对比增强CT扫描间的变异对影像组学特征可重复性的影响大于手动分割的变异;在相同条件下,胰腺肿瘤来源的可重复影像组学特征数量少于胰腺实质来源的特征。
研究设计与样本
- 经IRB批准且符合HIPAA的回顾性研究,纳入37例患者共37对间隔2周内的对比增强CT扫描用于胰腺实质特征分析,其中18对扫描进一步用于胰腺导管腺癌特征分析;由两名放射科医生独立手动分割,提取266个影像组学特征及肿瘤体积和直径。
诊断标准与关键数值
- 采用一致性相关系数(CCC)评估可重复性,阈值设定为CCC>0.90;胰腺实质来源特征在场景1(不同放射科医生、同一CECT)中58/266(21.8%)和48/266(18.1%)达标,场景2(同一放射科医生、不同CECT)中14/266(5.3%)和15/266(5.6%)达标,场景3(不同放射科医生、不同CECT)中14/266(5.3%)和10/266(3.8%)达标;胰腺肿瘤来源特征在场景1中11/268(4.1%)和17/268(6.3%)达标,场景2中1/268(0.4%)和5/268(1.9%)达标,场景3无特征达标。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aims to measure the reproducibility of radiomic features in pancreatic parenchyma and ductal adenocarcinomas (PDAC) in patients who underwent consecutive contrast-enhanced computed tomography (CECT) scans.
METHODS: In this IRB-approved and HIPAA-compliant retrospective study, 37 pairs of scans from 37 unique patients who underwent CECTs within a 2-week interval were included in the analysis of the reproducibility of features derived from pancreatic parenchyma, and a subset of 18 pairs of scans were further analyzed for the reproducibility of features derived from PDAC. In each patient, pancreatic parenchyma and pancreatic tumor (when present) were manually segmented by two radiologists independently. A total of 266 radiomic features were extracted from the pancreatic parenchyma and tumor region and also the volume and diameter of the tumor. The concordance correlation coefficient (CCC) was calculated to assess feature reproducibility for each patient in three scenarios: (1) different radiologists, same CECT; (2) same radiologist, different CECTs; and (3) different radiologists, different CECTs.
RESULTS: Among pancreatic parenchyma-derived features, using a threshold of CCC > 0.90, 58/266 (21.8%) and 48/266 (18.1%) features met the threshold for scenario 1, 14/266 (5.3%) and 15/266 (5.6%) for scenario 2, and 14/266 (5.3%) and 10/266 (3.8%) for scenario 3. Among pancreatic tumor-derived features, 11/268 (4.1%) and 17/268 (6.3%) features met the threshold for scenario 1, 1/268 (0.4%) and 5/268 (1.9%) features met the threshold for scenario 2, and no features for scenario 3 met the threshold, respectively.
CONCLUSIONS: Variations between CECT scans affected radiomic feature reproducibility to a greater extent than variation in segmentation. A smaller number of pancreatic tumor-derived radiomic features were reproducible compared with pancreatic parenchyma-derived radiomic features under the same conditions.
KEY POINTS: • For pancreatic-derived radiomic features from contrast-enhanced CT (CECT), fewer than 25% are reproducible (with a threshold of CCC < 0.9) in a clinical heterogeneous dataset. • Variations between CECT scans affected the number of reproducible radiomic features to a greater extent than variations in radiologist segmentation. • A smaller number of pancreatic tumor-derived radiomic features were reproducible compared with pancreatic parenchyma-derived radiomic features under the same conditions.
引用
- Yamashita R, Perrin T, Chakraborty J, et al. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation. Eur Radiol. 2019. PMID: 31392481. doi:10.1007/s00330-019-06381-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。